ArticleDrug and alcohol dependence2012
Illicit use of buprenorphine in a community sample of young adult non-medical users of pharmaceutical opioids.
Article in Drug and alcohol dependence, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed, 53 citations in OpenAlex.
- Methadone and buprenorphine-naloxone are effective in reducing illicit buprenorphine and other opioid use, and reducing HIV risk behavior--outcomes of a randomized trial.Drug and alcohol dependence · 2013Trial
- "I just wanted to tell you that loperamide WILL WORK": a web-based study of extra-medical use of loperamide.Drug and alcohol dependence · 2013Trial
- Trajectories of non-prescribed buprenorphine and other opioid use: A multi-trajectory latent class growth analysis.Journal of substance use and addiction treatment · 2023Article
- Scope of, Motivations for, and Outcomes Associated with Buprenorphine Diversion in the United States: A Scoping Review.Substance use & misuse · 2023Article
- Drug Abuse Ontology to Harness Web-Based Data for Substance Use Epidemiology Research: Ontology Development Study.JMIR public health and surveillance · 2022Article
- Unintentional drug overdose: Is more frequent use of non-prescribed buprenorphine associated with lower risk of overdose?The International journal on drug policy · 2020Article
- Characterization of diverted buprenorphine use among adults entering corrections-based drug treatment in Kentucky.Drug and alcohol dependence · 2020Article
- "Everything is not right anymore": Buprenorphine experiences in an era of illicit fentanyl.The International journal on drug policy · 2019Article
- Patterns of non-prescribed buprenorphine and other opioid use among individuals with opioid use disorder: A latent class analysis.Drug and alcohol dependence · 2019Article
- Non-prescribed use of methadone and buprenorphine prior to opioid substitution treatment: lifetime prevalence, motives, and drug sources among people with opioid dependence in five Swedish cities.Harm reduction journal · 2019Article
- Policy Pathways to Address Provider Workforce Barriers to Buprenorphine Treatment.American journal of preventive medicine · 2018Article
- Access to and Payment for Office-Based Buprenorphine Treatment in Ohio.Substance abuse : research and treatment · 2017Article
- Activated Carbon-Based System for the Disposal of Psychoactive Medications.Pharmaceutics · 2016Article
- Using respondent-driven sampling (RDS) to recruit illegal poly-substance users in Cape Town, South Africa: implications and future directions.Substance abuse treatment, prevention, and policy · 2016Article
- Policies related to opioid agonist therapy for opioid use disorders: The evolution of state policies from 2004 to 2013.Substance abuse · 2016Article
- Prior Experience with Non-Prescribed Buprenorphine: Role in Treatment Entry and Retention.Journal of substance abuse treatment · 2015Article
- Where Is Buprenorphine Dispensed to Treat Opioid Use Disorders? The Role of Private Offices, Opioid Treatment Programs, and Substance Abuse Treatment Facilities in Urban and Rural Counties.The Milbank quarterly · 2015Article
- "Sub is a weird drug:" A web-based study of lay attitudes about use of buprenorphine to self-treat opioid withdrawal symptoms.The American journal on addictions · 2015Article
- Self-management of buprenorphine/naloxone among online discussion board users.Substance use & misuse · 2014Article
- Correlates and Consequences of Opioid Misuse among High-Risk Young Adults.Journal of addiction · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
Abstract
backgroundThere is growing evidence about illicit use of buprenorphine in the U.S. The study aims to: (1) identify prevalence and predictors of illicit buprenorphine use in a community sample of 396 young adult (18-23 years old) non-medical users of pharmaceutical opioids and (2) describe knowledge, attitudes and behaviors linked to illicit buprenorphine use as reported by a qualitative sub-sample (n=51).
methodsParticipants were recruited using respondent-driven sampling. Qualitative interview participants were selected from the larger sample. The sample (n=396) was 54% male and 50% white; 7.8% reported lifetime illicit use of buprenorphine.
resultsLogistic regression analysis results indicate that white ethnicity, intranasal inhalation of pharmaceutical opioids, symptoms of opioid dependence, and a greater number of pharmaceutical opioids used in lifetime were statistically significant predictors of illicit buprenorphine use. Qualitative interviews revealed that buprenorphine was more commonly used by more experienced users who were introduced to it by their "junkie friends." Those who used buprenorphine to self-medicate withdrawal referred to it as a "miracle pill." When used to get high, reported experiences ranged from "the best high ever" to "puking for days." Participants reported using buprenorphine/naloxone orally or by intranasal inhalation. Injection of buprenorphine without naloxone was also reported.
conclusionOur findings suggest that illicit buprenorphine use is gaining ground primarily among whites and those who are more advanced in their drug use careers. Continued monitoring is needed to better understand evolving patterns and trends of illicit buprenorphine use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.